Clinical Efficacy of Ceftazidime/Avibactam for Treating Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae: A Systematic Review and Meta-Analysis
Carbapenem-resistant Klebsiella pneumoniae (CRKP) infections are challenging to treat owing to high-level resistance, limited therapeutic options, and inconsistent treatment duration. Ceftazidime-avibactam (CAZ-AVI) has emerged as a promising option for carbapenem-resistant Enterobacterales infections, but comparative...